Unknown

Dataset Information

0

Sustained delivery of proangiogenic microRNA-132 by nanoparticle transfection improves endothelial cell transplantation.


ABSTRACT: Transplantation of endothelial cells (ECs) for therapeutic vascularization or tissue engineering is a promising method for increasing tissue perfusion. Here, we report on a new approach for enhanced EC transplantation using targeted nanoparticle transfection to deliver proangiogenic microRNA-132 (miR-132) to cultured ECs before their transplantation, thereby sensitizing cells to the effects of endogenous growth factors. We synthesized biodegradable PLGA polymer nanoparticles (NPs) that were loaded with miR-132 and coated with cyclic RGD (cRGD) peptides that target integrin ?v?3 expressed on cultured human umbilical vein ECs (HUVECs), increasing NP uptake through clathrin-coated pits. Unlike previously reported NPs for miR delivery, these NPs slowly release RNA for several weeks. The endocytosed NPs remain in clathrin-coated vesicles from which they mediate intracellular delivery of siRNA or miRNA. Transfection of HUVECs with miR-132 enhances growth factor-induced proliferation and migration in 2D culture, producing a 1.8- and 5-fold increase, respectively. However, while the effects of conventional transfection were short-lived, NP transfection produced protein knockdown and biological effects that were significantly longer in duration (? 6 d). Transfection of HUVECs with miR-132 NP resulted in a 2-fold increase in the number of microvessels per square millimeter compared to lipid after transplantation into immunodeficient mice and led to a higher number of mural cell-invested vessels than control transfection. These data suggest that sustained delivery of miR-132 encapsulated in a targeted biodegradable polymer NP is a safe and efficient strategy to improve EC transplantation and vascularization.

SUBMITTER: Devalliere J 

PROVIDER: S-EPMC3898640 | biostudies-literature | 2014 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Sustained delivery of proangiogenic microRNA-132 by nanoparticle transfection improves endothelial cell transplantation.

Devalliere Julie J   Chang William G WG   Andrejecsk Jillian W JW   Abrahimi Parwiz P   Cheng Christopher J CJ   Jane-wit Dan D   Saltzman W Mark WM   Pober Jordan S JS  

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20131112 2


Transplantation of endothelial cells (ECs) for therapeutic vascularization or tissue engineering is a promising method for increasing tissue perfusion. Here, we report on a new approach for enhanced EC transplantation using targeted nanoparticle transfection to deliver proangiogenic microRNA-132 (miR-132) to cultured ECs before their transplantation, thereby sensitizing cells to the effects of endogenous growth factors. We synthesized biodegradable PLGA polymer nanoparticles (NPs) that were load  ...[more]

Similar Datasets

| S-EPMC4477514 | biostudies-literature
2021-08-04 | GSE181333 | GEO
| S-EPMC7591136 | biostudies-literature
| S-EPMC7328311 | biostudies-literature
| PRJNA751588 | ENA
| S-EPMC4740885 | biostudies-other
2023-10-13 | GSE242338 | GEO
| S-EPMC7072816 | biostudies-literature
| S-EPMC9389749 | biostudies-literature
| S-EPMC8025840 | biostudies-literature